Advertisement
Surgery
Subscribe to Surgery
View Sample

FREE Email Newsletter

Ovarian Cancer Genome Mapped, Opens Door to Personalized Medicine

June 29, 2011 9:36 am | by Lawrence Berkeley National Laboratory | News | Comments

Scientists have developed the first comprehensive catalog of the genetic aberrations responsible for an aggressive type of ovarian cancer that accounts for 70 percent of all ovarian cancer deaths. Hundreds of researchers from more than 80 institutions, including scientists from Berkeley...

Ascension Orthopedics Implants PyroTITANâ„¢ in Geelong, Australia

June 29, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, June 29, 2011 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. Page, MB.BS.FRACS(ORTH) at St. John of God Hospital. "The...

Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index

June 27, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., June 27, 2011 /- Pacira Pharmaceuticals, Inc ., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that it has been included in the Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and...

Advertisement

New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes

June 22, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 22, 2011 /- Allergan, Inc. (NYSE: AGN ) today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND® Adjustable...

ProStrakan Receives FDA Approval for Rectivâ„¢ for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures

June 22, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

GALASHIELS, Scotland, and BEDMINSTER, N.J., June 22, 2011 /- ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for...

MedShape Solutions, Inc. Announces Extension of ExoShapeâ„¢ Product Line in Response to Surgeon Demand

June 20, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 20, 2011 /- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced it has developed new, larger sizes of its ExoShape CL, a two-part PEEK Altera™ interference fixation device that simplifies and improves soft tissue...

BioMedixâ„¢ Announces John Martin, MD, FACS, as Medical Director

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAINT PAUL, Minn., June 16, 2011 /- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only...

Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 16, 2011 /- The largest human dermal allograft available on the market today for hernia and abdominal wall repair will be introduced at the AWR meeting here this week.  The Musculoskeletal Transplant Foundation (MTF), the nation's leading tissue bank, is introducing...

Advertisement

Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016

June 16, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 16, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: US Wound Closure Devices – Market Trend Till 2016...

Covidien Announces Organizational Changes(2)

June 15, 2011 5:34 pm | by Covidien | News | Comments

DUBLIN, Jun 15, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced several leadership changes that will streamline its organization to accelerate growth and innovation. These changes are all effective July 1, 2011. Bryan C....

Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011

June 15, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 15, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011...

FDA Approves First Ceramic-on-Metal Total Hip Replacement System

June 14, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved on June 13 the first ceramic-on-metal total artificial hip system for patients with osteoarthritis. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Hip joints...

ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital

June 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

FORT LAUDERDALE, Fla., June 14, 2011 /- ANF Group, Inc ., a South Florida based construction management firm, announced today the completion of the 170,000-square-foot Joe DiMaggio Children's Hospital – the first free standing children's hospital in Broward County. (Photo:...

Advertisement

Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPARELâ„¢ PDUFA Target Date by Three Months

June 14, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., June 14, 2011 /- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug...

Phase I Pro-Vas® Effectiveness Study Presented at AUA Meeting

June 8, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 8, 2011 /PRNewswire/ -- A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas® occlusion as a highly promising method of permanent male sterilization. The clinical study results were presented by...

StreamVenue Healthcare Connects Endoscopy Technology With Athletic Trainers

June 8, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 8, 2011 /- StreamVenue Healthcare has partnered its "plug and play" products and services with Texas Health Ben Hogan Sports Medicine to teach, and to better manage post-surgical patient recovery. StreamVenue's system, StreamingOR, allows athletic trainers, surgeons and...

Healthmark Industries Honored With Two Awards

June 7, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

FRASER, Mich., June 7, 2011 /- Healthmark Industries was honored with two award wins last week from the Michigan Society of Healthcare Central Service Personnel (MSHCSP). At last week's annual meeting, Director of Education, Stephan Kovach was presented with the Lifetime Honorary...

Keeping Neurons Alive in Parkinson's Patients

June 5, 2011 8:34 pm | by Massachusetts Institute of Technology | News | Comments

An upcoming clinical trial will attempt to solve problems that have plagued one potentially promising treatment.

Pioneer Surgical Awarded HealthTrust Contract for Spinal Implants

June 3, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

MARQUETTE, Mich., June 3, 2011 /- HealthTrust Purchasing Group, L.P., (HealthTrust) has awarded Pioneer Surgical Technology, Inc. (Pioneer Surgical) a spine implant agreement, beginning June 1, 2011. "We are very pleased to be a part of HealthTrust's new spine implant agreement. Our...

Manufacturer of Motors, Powered Surgical Devices, Motion Control Products

June 2, 2011 12:36 pm | Pro-Dex | Product Releases | Comments

Established in 1975, Pro-Dex Inc. has grown to specialize in the design, development and contract manufacture of everything from components, motors and subassemblies to complete powered surgical devices.

Covidien's hernia mesh gets U.S. and European OK

June 2, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Covidien plc has won approval in both the U.S. and Europe to market its Parietex Optimized Composite (PCOx) mesh used in surgical hernia repair, the company said today.

Covidien Announces U.S. 510(k) Clearance and European CE Mark Approval of Parietex(TM) Optimized Composite Mesh

June 2, 2011 12:33 am | by Covidien | News | Comments

New product features optimized protection, integration and handling during laparoscopic ventral hernia repair NORTH HAVEN, Conn., Jun 02, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug...

Major NHS Trust Reports Rise in Volunteers in the Wake of the Recession

June 1, 2011 4:34 am | by RealWire | News | Comments

As Volunteers' Week gets underway, University Hospitals Coventry and Warwickshire NHS Trust (UHCW) has highlighted the growing number of people who are giving up their time to help deliver services.The Trust is just one workplace which enables and encourages volunteering, enjoying the...

BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress

June 1, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

LYNBROOK, N.Y., June 1, 2011 /- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that positive data for XIAPEX® (clostridial collagenase histolyticum for injection) were presented at the...

Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results

June 1, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

BOULDER, Colo., June 1, 2011 /- Encision Inc. (Pink Sheets: ECIA ), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011....

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading